Pinpointing Global Expertise in Non-Alcoholic Fatty Liver Disease (NAFLD)

2019-04-17T10:00:35Z (GMT) by Digital Science
Disease types associated with NAFLD present a tremendous research and development challenge for life sciences organizations and also a great opportunity for them to create value and innovation.<br><br>The NASH market alone was valued at $1,179 million in 2017, and is expected to reach $21,478 million by 2025, growing at a CAGR of 58.4% from 2021 to 2025 1.<br><br>Digital Science offers the data capabilities to help information services leaders, discovery scientists, CI analysts, knowledge management, partnering and business development professionals uncover insights and expertise in disease-related topics and key indication areas.<br><br>This graphic shows some example insights in non-alcoholic fatty liver disease (NAFLD) and its common disease type NASH (non-alcoholic steatohepatitis) extracted from our Dimensions platform: <a href="https://app.dimensions.ai/discover/publication">https://app.dimensions.ai/discover/publication</a>.